Grant: Discovery Grants Program - Individual
University of Alberta
$82,900.00
Antibiotic production by Streptomyces clavuligerus
EF 2007-08
Résumé
Antibiotics produced by microbes are a main defense against infectious diseases, but their effectiveness is being threatened. Pathogenic bacteria are developing resistance to many of our most useful drugs at an alarming rate. Clavulanic acid is a beta-lactamase inhibitor that is widely used together with penicillin and cephalosporin antibiotics to overcome resistance mediated by production of beta-lactamases. All clavulanic acid used clinically comes from fermentations of the organism, Streptomyces clavuligerus. Production of clavulanic acid is being studied to understand how the appearance and disappearance of the biosynthetic enzymes involved in its synthesis is regulated in S. clavuligerus. The genes encoding these biosynthetic enzymes are spread across three gene clusters in the chromosome, and each gene cluster is regulated differently. We use mutagenesis and analysis of the resulting mutants to investigate the details of the biosynthesis of clavulanic acid biosynthesis. Studies on regulatory genes clarify the conditions under which the various biosynthetic enzymes will be produced. These studies could lead to more efficient production of existing antibiotics or possibly to the development of new types of antibiotics.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
2824-2006
Name nom
Jensen, Susan
Department département
Biological Sciences
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
82900
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
2
Nb partie
5
Application title
Antibiotic production by Streptomyces clavuligerus
Keyword
NA
Application summary
Antibiotics produced by microbes are a main defense against infectious diseases, but their effectiveness is being threatened. Pathogenic bacteria are developing resistance to many of our most useful drugs at an alarming rate. Clavulanic acid is a beta-lactamase inhibitor that is widely used together with penicillin and cephalosporin antibiotics to overcome resistance mediated by production of beta-lactamases. All clavulanic acid used clinically comes from fermentations of the organism, Streptomyces clavuligerus. Production of clavulanic acid is being studied to understand how the appearance and disappearance of the biosynthetic enzymes involved in its synthesis is regulated in S. clavuligerus. The genes encoding these biosynthetic enzymes are spread across three gene clusters in the chromosome, and each gene cluster is regulated differently. We use mutagenesis and analysis of the resulting mutants to investigate the details of the biosynthesis of clavulanic acid biosynthesis. Studies on regulatory genes clarify the conditions under which the various biosynthetic enzymes will be produced. These studies could lead to more efficient production of existing antibiotics or possibly to the development of new types of antibiotics.